投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2018年中国人文章占该期刊总数量暂无数据 (2017年为暂无数据)
自引率
暂无数据
年文章数
0
投稿链接
未知
作者需知
暂无数据
NCBI查询
偏重的研究方向
暂无数据
期刊简介
稿件收录要求
稿件收录要求
Published by Thomson Current Drugs.
ISSN: 1367-6733.
Current Opinion in Drug Discovery & Development is designed to give you an intelligent overview of the most important developments across this entire field of research. We make it easier for you to follow the progress made in each area from year to year by dividing the whole subject into sections and systematically reviewing the highlights. The journal encompasses all of the chemical processes within the drug product cycle, from the initial concept stage, through to process development. All new discoveries of new chemical entities, intermediates, synthetic pathways, formulations and the latest developments in enabling technologies disclosed within patents, journal articles and meetings are discussed. It provides a unique forum for the discussion of current developments in the field. The journal contains the views of experts in the form of editorial overviews, review articles, annotated paper and patent selections, and a web watch selection.
Current Opinion in Drug Discovery & Development is designed to give you an intelligent overview of the most important developments across this entire field of research. We make it easier for you to follow the progress made in each area from year to year by dividing the whole subject into sections and systematically reviewing the highlights. The journal encompasses all of the chemical processes within the drug product cycle, from the initial concept stage, through to process development. All new discoveries of new chemical entities, intermediates, synthetic pathways, formulations and the latest developments in enabling technologies disclosed within patents, journal articles and meetings are discussed. It provides a unique forum for the discussion of current developments in the field. The journal contains the views of experts in the form of editorial overviews, review articles, annotated paper and patent selections, and a web watch selection.
